Comparable transplant outcomes between local and shipped deceased-donor kidneys in Australia: analysis of Australia and New Zealand Dialysis and Transplant Registry 1992-2007
- PMID: 20377780
- DOI: 10.1111/j.1440-1797.2009.01199.x
Comparable transplant outcomes between local and shipped deceased-donor kidneys in Australia: analysis of Australia and New Zealand Dialysis and Transplant Registry 1992-2007
Abstract
Aim: Allocation of deceased-donor kidneys in Australia often involves the shipping of well-matched renal allografts across states. However, the impact of shipping on graft outcomes remains unclear. In this study, the effect of shipping of well-matched (0-2 human leucocyte antigen (HLA) mismatches) and poorer-matched (3-6 HLA mismatches) deceased-donor kidneys on transplant outcomes in Australia were examined.
Methods: Using data from Australia and New Zealand Dialysis and Transplant Registry (ANZDATA), graft and patient outcomes were compared between shipped and locally transplanted allografts in Australia between 1992 and 2007 stratified by the number of HLA mismatches.
Results: Recipients receiving shipped renal allografts were more likely to be highly sensitized with previous grafts and/or higher panel reactive antibodies levels with significantly longer graft ischaemic time compared to local allografts. Regardless of the HLA mismatches, the risk of delayed graft function, acute rejection, 12 month serum creatinine, graft failure and patient survival was similar between shipped and locally transplanted renal allografts.
Conclusion: Recipients of shipped renal allografts with 0-2 and 3-6 HLA mismatches have similar transplant outcomes to locally transplanted allografts.
Similar articles
-
Effect on graft and patient survival between shipped and locally transplanted well-matched cadaveric renal allografts in Australia over a 10-year period.Nephrology (Carlton). 2006 Feb;11(1):73-7. doi: 10.1111/j.1440-1797.2006.00525.x. Nephrology (Carlton). 2006. PMID: 16509937
-
Interleukin-2 receptor antibody does not reduce rejection risk in low immunological risk or tacrolimus-treated intermediate immunological risk renal transplant recipients.Nephrology (Carlton). 2010 Apr;15(3):368-76. doi: 10.1111/j.1440-1797.2009.01259.x. Nephrology (Carlton). 2010. PMID: 20470309
-
Kidney transplantation in the United States.Clin Transpl. 2008:1-18. Clin Transpl. 2008. PMID: 19711510
-
A review of utility-based allocation strategies to maximize graft years of deceased donor kidneys.Nephrology (Carlton). 2011 May;16(4):368-76. doi: 10.1111/j.1440-1797.2011.01445.x. Nephrology (Carlton). 2011. PMID: 21265932 Review.
-
HLA compatibility and organ transplant survival. Collaborative Transplant Study.Rev Immunogenet. 1999;1(3):334-42. Rev Immunogenet. 1999. PMID: 11256424 Review.
Cited by
-
Prostate Cancer Characteristics in Renal Transplant Recipients: A 25-Year Experience From a Single Centre.Front Surg. 2021 Jul 29;8:716861. doi: 10.3389/fsurg.2021.716861. eCollection 2021. Front Surg. 2021. PMID: 34395512 Free PMC article.
-
Impact of distance between donor and recipient hospitals on cadaveric kidney transplantation outcomes.Clin Exp Nephrol. 2019 Jun;23(6):807-813. doi: 10.1007/s10157-019-01710-z. Epub 2019 Feb 27. Clin Exp Nephrol. 2019. PMID: 30809748
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials